Ultrahuman and Click Therapeutics have announced the launch of the Migraine PowerPlug, a groundbreaking software integration for the Ultrahuman app. It represents the first collaboration to combine real-time wearable biomarkers with CT-132, Click’s proprietary technology, and the first FDA-authorized digital therapeutic for the preventive treatment of episodic migraine.

The Frontiers Health Connection

Both companies were prominent contributors to FH2025 in Berlin:

• Click Therapeutics acted as a Strategic Partner for the event, with CEO David Benshoof Klein leading discussions on the future of "software-enhanced drugs." WATCH MORE
   
• Rob Milnes, SVP Women's Health & Longevity at Ultrahuman, was an active participant in sessions regarding the convergence of consumer health data and clinical outcomes and on the M&A panel led by Mark Slujis on their successful acquisition of Vio HealthTech. He also joined FemTech pioneers to explore the realities of their cutting-edge innovations for the women’s health space. WATCH MORE

Source: www.globenewswire.com